Recruiting NA Premature

New treatment option for Premature

Official title Enteral Feeding of Premature Babies and Olive Oil Supplementation

ClinicalTrials.gov ID: NCT06072625

What this study is testing

What it's testing
It is a two-arm prospective interventional study. 40 babies in both groups will be enrolment in the study.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 14 to 40. Healthy volunteers may be eligible.

You may be able to join if

  • Premature babies born at 32 weeks or less
  • Babies who tolerate full enteral feeding at the before end of the second week
  • Babies given consent by their parents -

You likely can't join if

  • Having a congenital or genetic anomaly

The study team makes the final eligibility decision.

Where it's taking place

  • Bursa, Turkey (Türkiye)

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 14 days to 40 days. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Bursa, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.